Wegovy is also FDA-approved to treat metabolic dysfunction-associated steatohepatitis (MASH), a condition that causes inflammation and scarring in the liver, including more serious scarring called advanced fibrosis
Before initiating SYMLIN, the patient's HbA 1c , recent blood glucose monitoring data, history of insulin-induced hypoglycemia, current insulin regimen, and body weight should be reviewed
Its actually higher than weve seen most companies achieve
Youve probably heard of injectable drugs that are used to treat diabetes
(1999a) Nonsaturable entry of neuropeptide Y into the brain
The US contributed the majority of the regions revenue, accounting for 95.2% of the weight-loss medication segment